From Marine Venoms to Drugs: Efficiently Supported by a Combination of Transcriptomics and Proteomics
AbstractThe potential of marine natural products to become new drugs is vast; however, research is still in its infancy. The chemical and biological diversity of marine toxins is immeasurable and as such an extraordinary resource for the discovery of new drugs. With the rapid development of next-generation sequencing (NGS) and liquid chromatography–tandem mass spectrometry (LC-MS/MS), it has been much easier and faster to identify more toxins and predict their functions with bioinformatics pipelines, which pave the way for novel drug developments. Here we provide an overview of related bioinformatics pipelines that have been supported by a combination of transcriptomics and proteomics for identification and function prediction of novel marine toxins. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Xie, B.; Huang, Y.; Baumann, K.; Fry, B.G.; Shi, Q. From Marine Venoms to Drugs: Efficiently Supported by a Combination of Transcriptomics and Proteomics. Mar. Drugs 2017, 15, 103.
Xie B, Huang Y, Baumann K, Fry BG, Shi Q. From Marine Venoms to Drugs: Efficiently Supported by a Combination of Transcriptomics and Proteomics. Marine Drugs. 2017; 15(4):103.Chicago/Turabian Style
Xie, Bing; Huang, Yu; Baumann, Kate; Fry, Bryan G.; Shi, Qiong. 2017. "From Marine Venoms to Drugs: Efficiently Supported by a Combination of Transcriptomics and Proteomics." Mar. Drugs 15, no. 4: 103.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.